|

Clofarabine Clinical Trials

7 actively recruiting trials across 2 locations

▲ +1 trial since May 2026

Also known as: Clofarex, Clolar

Pipeline

Phase 2: 6Phase 1/2: 1

Top Sponsors

  • Nantes University Hospital2
  • Memorial Sloan Kettering Cancer Center2
  • M.D. Anderson Cancer Center2
  • Ekaterina Laukhtina1

Indications

  • Cancer7
  • Graft-versus-host-disease2
  • Refractory Acute Lymphoblastic Leukemia2
  • Acute Lymphoblastic Leukemia2
  • HLH1

Other3 trials

Clofarabine Therapy in Locally Advanced or Metastatic Urothelial Carcinoma
Phase 1/2
Study Comparing the Efficacy of 2 RIC Regimens (Clofarabine vs Fludarabine) in Adults With AML Eligible to Allo-SCT
Phase 2
Study Testing Two Conditioning Regimen With a Single Prophylaxis of GVHD by Cyclophosphamide and Methotrexate Post-transplant in Patients Eligible for Matched-donor Allograft Transplantation
Phase 2

New York, New York2 trials

Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders

Memorial Sloan Kettering Cancer Center

Phase 2
Cord Blood Transplantation in Children and Young Adults With Blood Cancer

Memorial Sloan Kettering Cancer Center (All Protocol Activities)

Phase 2

Houston, Texas2 trials

Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia

M D Anderson Cancer Center

Phase 2
Personalized NK Cell Therapy in CBT

M D Anderson Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.